Drug Trial Radar · NCT04360187
Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis
Last checked: Nov 20, 2026Latest source record: Jun 7, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
391
Actual
Start
Jul 27, 2020
Primary completion
Sep 8, 2021
Study completion Sep 8, 2021
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Apr 24, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a phase 3, randomized, double blind and vehicle study to evaluate the efficacy and safety of Crisaborole ointment, 2% in Chinese and Japanese subjects with mild to moderate atopic dermatitis involving at least 5% treatable BSA. Eligible subjects will be randomized in a 2:1 ratio to one of 2 treatment groups (Crisaborole BID, Vehicle BID, respectively).
Conditions
- Atopic Dermatitis
Interventions
Crisaborole OintmentDrug
Crisaborole ointment 2%
Crisaborole Placebo VehicleDrug
Placebo for crisaborole ointment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Day 29Time frame: Baseline, Day 29
- Percentage of Participants With Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events (SAEs)Time frame: Baseline up to Day 60
- Percentage of Participants With Clinically Significant Changes From Baseline in Clinical Laboratory ParametersTime frame: Baseline up to Day 29
- Percentage of Participants With Clinically Significant Changes From Baseline in Vital SignsTime frame: Baseline up to Day 29
Locations
39 sites in 3 countries. Site status is shown where the registry gives one.
Peking University People's Hospital
Beijing, China
Beijing Children's Hospital, Capital Medical University
Beijing, China
The Second Affiliated Hospital of Army Medical University,PLA
Chongqing, China
Children's Hospital of Shanghai
Shanghai, China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, China
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China
Guangzhou First People's Hospital
Guangzhou, Guangdong, China
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
The First Affiliated Hospital of Shantou University Medical College
Shantou, Guangdong, China
Shenzhen Children's Hospital
Shenzhen, Guangdong, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
The First hospital of Jilin University
Changchun, Jilin, China
Shandong Provincial Institute of Dermatology and Venereology & Shandong Provincial Hospital for Skin
Jinan, Shandong, China
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Hangzhou Third Hospital
Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital/Dermatology Department
Hangzhou, Zhejiang, China
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
The first Affiliated hospital of Wenzhou medical University
Wenzhou, Zhejiang, China
Hoshikuma Dermatology・Allergy Clinic
Fukuoka, Japan
Miyata Dermatology Clinic
Matsudo, Chiba, Japan
Shirao Clinic of Pediatrics and Pediatric Allergy
Hiroshima, Hiroshima, Japan
Motomachi Dermatology Clinic
Asahikawa-shi, Hokkaido, Japan
Chitose dermatology and plastic surgery clinic
Chitose Shi, Hokkaido, Japan
Takagi Dermatological Clinic
Obihiro, Hokkaido, Japan
Yoshimura Child Clinic
Akashi, Hyōgo, Japan
Iryouhoujinshadan Yamayurikai Tsujino. Kodomo Clinic
Kobe, Hyōgo, Japan
Nomura Dermatology Clinic
Yokohama, Kanagawa, Japan
Noguchi Dermatology Clinic
Kamimashiki-gun, Kumamoto, Japan
Yoshioka Dermatology Clinic
Neyagawa, Osaka, Japan
Kume Clinic
Sakai, Osaka, Japan
Mildix Skin Clinic
Adachi-ku, Tokyo, Japan
Yoga Allergy Clinic
Setagaya-ku, Tokyo, Japan
Sugamo Kobayashi Derma Clinic
Toshima-Ku, Tokyo, Japan
Sugamo Sengoku Dermatology
Toshima-Ku, Tokyo, Japan
Hallym University Kangnam Sacred Heart Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.